Reviva Pharmaceuticals Holdings, Inc. (RVPH) Financials
RVPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 21.1 trillion | 5.9 trillion |
| March 31, 2026 | 23.6 million | 6.1 million |
| Dec. 31, 2025 | 15.9 million | 7.3 million |
| Sept. 30, 2025 | 14.3 million | 9.8 million |
RVPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -5.9 trillion | 799.0 billion |
| March 31, 2026 | -3.8 million | 584439 |
| Dec. 31, 2025 | -5.8 million | 455084 |
| Sept. 30, 2025 | -5.6 million | 458379 |
RVPH Net Income
No data available :(
RVPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 19.9 trillion | - | - |
| March 31, 2026 | 22.2 million | - | - |
| Dec. 31, 2025 | 14.4 million | - | - |
| Sept. 30, 2025 | 13.2 million | - | - |
RVPH Shares Outstanding
RVPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 1.4 trillion | 1.2 trillion | - |
| March 31, 2026 | - | 1.4 million | 1.8 million | - |
| Dec. 31, 2025 | 4 | 1.7 million | 1.8 million | - |
| Sept. 30, 2025 | 4 | 2.1 million | 1.9 million | - |
RVPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
RVPH
Price: $0.45
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71600
Market Capitalization: 6.4 million